Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma

被引：1
|
作者：
Yin, Zhao [1 ]
Zhang, Qing [1 ]
Ou, Ruiming [1 ]
Liu, Shuang [1 ]
机构：
[1] Guangdong Second Prov Gen Hosp, Dept Hematol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 25期
关键词：
D O I：
10.1200/JCO.24.00544
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CAR T-cell therapy for relapsed or refractory multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (06): : E297 - E297
  • [42] Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma
    Hasanali, Zainul S.
    Razzo, Beatrice
    Susanibar-Adaniya, Sandra P.
    Garfall, Alfred L.
    Stadtmauer, Edward A.
    Cohen, Adam D.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 383 - 406
  • [43] Safety and efficacy of a locally produced novel anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory multiple myeloma
    Lebel, Eyal
    Kfir-Erenfeld, Shlomit
    Asherie, Nathalie
    Grisariu, Sigal
    Avni, Batia
    Elias, Shlomo
    Assayag, Miri
    Dubnikov, Tatyana
    Zalcman, Nomi
    Pick, Marjorie
    Zimran, Eran
    Shaulov, Adir
    Cohen, Yael
    Avivi, Irit
    Cohen, Cyrille
    Stepensky, Polina
    Gatt, Moshe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S47 - S48
  • [44] BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma
    Yang, Jinrong
    Zhou, Weilin
    Li, Dan
    Niu, Ting
    Wang, Wei
    CANCER LETTERS, 2023, 553
  • [45] Chimeric antigen receptor T cell therapy for multiple myeloma
    Kana Hasegawa
    Naoki Hosen
    Inflammation and Regeneration, 39
  • [46] Chimeric antigen receptor T cell therapies for multiple myeloma
    Wu, Chao
    Zhang, Lina
    Brockman, Qierra R.
    Zhan, Fenghuang
    Chen, Lijuan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [47] Chimeric antigen receptor T cell therapies for multiple myeloma
    Chao Wu
    Lina Zhang
    Qierra R. Brockman
    Fenghuang Zhan
    Lijuan Chen
    Journal of Hematology & Oncology, 12
  • [48] Chimeric antigen receptor T cell therapy for multiple myeloma
    Hasegawa, Kana
    Hosen, Naoki
    INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [49] An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis
    Pereira, Rita
    Bergantim, Rui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [50] Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China
    Wang, Baiyan
    Liu, Jie
    Zhao, Wan-Hong
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Fan, Frank Xiao-Hu
    Zhang, Wang-Gang
    He, Ai-Li
    BLOOD, 2020, 136
12345